Marimed (MRMD) Insider Filing: 11,517 RSUs Converted, 3,381 Shares Withheld

Rhea-AI Filing Summary

Jon R. Levine, who is listed as President and CEO, Director, and a 10% owner of Marimed Inc. (MRMD), reported transactions on 10/02/2025. 11,517 restricted stock units (RSUs) vested and were converted one-for-one into common shares; the filing shows an acquisition of 11,517 shares at a $0 price component and a separate disposition of 3,381 shares withheld by the issuer to satisfy tax-withholding obligations at a price of $0.161 per share. After these reported transactions, the filing lists 20,855,370 shares beneficially owned directly and 6,684,640 shares held indirectly by the Jon Levine Family Trust for the benefit of his spouse and children (the reporting person disclaims beneficial ownership of the trust shares). The RSU grant referenced was originally awarded on April 2, 2024 and remaining installments vest in three equal parts on April 2, 2026, October 2, 2026, and April 2, 2027.

Positive

• 11,517 RSUs vested and converted to common shares, increasing the reporting person's direct holdings
• Direct beneficial ownership after transactions remains substantial at 20,855,370 shares

Negative

• 3,381 shares were withheld by the issuer to satisfy tax-withholding obligations
• A large block of 6,684,640 shares is held indirectly in a family trust (reporting person disclaims beneficial ownership)

Insights

Corporate Governance / Insider Transactions Analyst

TL;DR: CEO Jon R. Levine had 11,517 RSUs vest and increased reported direct holdings to 20,855,370 shares after tax withholding of 3,381 shares.

The filing documents the vesting conversion of 11,517 RSUs into common stock on 10/02/2025, with the issuer withholding 3,381 shares to satisfy taxes at a price shown as $0.161 per share.

The report also discloses 6,684,640 shares held indirectly in the Jon Levine Family Trust, which the reporting person disclaims beneficial ownership of; the filing therefore separates direct and indirect positions explicitly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Levine Jon R

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/02/2025		M		11,517	A	$0(1)	20,858,751	D
Common stock	10/02/2025		F		3,381(2)	D	$0.161	20,855,370	D
Common stock								6,684,640	I	By the Jon Levine Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	10/02/2025		M			11,517	(4)	(4)	Common Stock, par value $.001 per share	11,517	$0	34,552	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. These RSUs were granted on April 2, 2024; the remaining RSUs will vest in three equal installments on each of April 2, 2026, October 2, 2026 and April 2, 2027 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Jon R. Levine	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MRMD CEO Jon R. Levine report on 10/02/2025?

He reported the vesting and conversion of 11,517 RSUs into common stock and the withholding of 3,381 shares for tax obligations.

How many MRMD shares does Jon R. Levine beneficially own after the reported transactions?

The filing shows 20,855,370 shares owned directly following the transactions and 6,684,640 shares held indirectly by the Jon Levine Family Trust.

What was the withholding price per share for tax purposes on the RSU vesting?

The filing reflects withheld shares at a price of $0.161 per share.

When were the RSUs originally granted and when do remaining installments vest?

The RSUs were granted on April 2, 2024; remaining RSUs vest in three equal installments on April 2, 2026, October 2, 2026, and April 2, 2027.

Does Jon R. Levine claim beneficial ownership of the shares held in the family trust?

No; the filing states the reporting person disclaims beneficial ownership of the 6,684,640 trust-held shares.